128 related articles for article (PubMed ID: 8904376)
1. Mupirocin-resistant methicillin-resistant Staphylococcus aureus.
Ambler JE; Drabu YJ
J Hosp Infect; 1996 Jan; 32(1):71-82. PubMed ID: 8904376
[No Abstract] [Full Text] [Related]
2. [Topical antibiotics and clinical use].
Cesur S
Mikrobiyol Bul; 2002; 36(3-4):353-61. PubMed ID: 12838671
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility of skin and soft-tissue isolates of Staphylococcus aureus and Streptococcus pyogenes to topical antibiotics: indications of clonal spread of fusidic acid-resistant Staphylococcus aureus.
Afset JE; Maeland JA
Scand J Infect Dis; 2003; 35(2):84-9. PubMed ID: 12693555
[TBL] [Abstract][Full Text] [Related]
4. Comparison of silver sulfadiazine 1%, mupirocin 2%, and fusidic acid 2% for topical antibacterial effect in methicillin-resistant staphylococci-infected, full-skin thickness rat burn wounds.
Acikel C; Oncul O; Ulkur E; Bayram I; Celikoz B; Cavuslu S
J Burn Care Rehabil; 2003; 24(1):37-41. PubMed ID: 12543989
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of a new cream formulation of mupirocin: comparison with oral and topical agents in experimental skin infections.
Gisby J; Bryant J
Antimicrob Agents Chemother; 2000 Feb; 44(2):255-60. PubMed ID: 10639346
[TBL] [Abstract][Full Text] [Related]
6. Mupirocin resistance and methicillin-resistant Staphylococcus aureus (MRSA).
Eltringham I
J Hosp Infect; 1997 Jan; 35(1):1-8. PubMed ID: 9032630
[TBL] [Abstract][Full Text] [Related]
7. Emergence of high-level mupirocin resistance in methicillin-resistant Staphylococcus aureus isolated from Brazilian university hospitals.
Netto dos Santos KR; de Souza Fonseca L; Gontijo Filho PP
Infect Control Hosp Epidemiol; 1996 Dec; 17(12):813-6. PubMed ID: 8985770
[TBL] [Abstract][Full Text] [Related]
8. High usage of topical fusidic acid and rapid clonal expansion of fusidic acid-resistant Staphylococcus aureus: a cautionary tale.
Williamson DA; Monecke S; Heffernan H; Ritchie SR; Roberts SA; Upton A; Thomas MG; Fraser JD
Clin Infect Dis; 2014 Nov; 59(10):1451-4. PubMed ID: 25139961
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of disseminated methicillin-resistant Staphylococcus aureus with fosfomycin, cefoperazone/sulbactam and rifampin followed by fusidic acid and rifampin.
Apisarnthanarak A; Mundy LM
Int J Infect Dis; 2007 May; 11(3):283-4. PubMed ID: 16876452
[No Abstract] [Full Text] [Related]
10. Topical mupirocin for eradication of MRSA colonization with mupirocin-resistant strains.
Semret M; Miller MA
Infect Control Hosp Epidemiol; 2001 Sep; 22(9):578-80. PubMed ID: 11732789
[TBL] [Abstract][Full Text] [Related]
11. Development of mupirocin resistance among methicillin-resistant Staphylococcus aureus after widespread use of nasal mupirocin ointment.
Miller MA; Dascal A; Portnoy J; Mendelson J
Infect Control Hosp Epidemiol; 1996 Dec; 17(12):811-3. PubMed ID: 8985769
[TBL] [Abstract][Full Text] [Related]
12. Fusidic acid in the treatment of methicillin-resistant Staphylococcus aureus.
Whitby M
Int J Antimicrob Agents; 1999 Aug; 12 Suppl 2():S67-71. PubMed ID: 10528788
[TBL] [Abstract][Full Text] [Related]
13. Eradicating methicillin-resistant Staphylococcus aureus.
Chapnick EK; Gradon JD; Levi M; Lutwick LI
JAMA; 1992 Mar; 267(12):1612. PubMed ID: 1542164
[No Abstract] [Full Text] [Related]
14. Observations on high levels of fusidic acid resistant Staphylococcus aureus in Harrogate, North Yorkshire, UK.
Ravenscroft JC; Layton A; Barnham M
Clin Exp Dermatol; 2000 Jun; 25(4):327-30. PubMed ID: 10971497
[TBL] [Abstract][Full Text] [Related]
15. How resistant is Staphylococcus aureus to the topical antibiotic mupirocin?
Rakshit T; Shenoy M S
J Glob Antimicrob Resist; 2017 Mar; 8():102-103. PubMed ID: 28082145
[No Abstract] [Full Text] [Related]
16. The use of mupirocin in controlling methicillin-resistant Staphylococcus aureus.
Neu HC
Infect Control Hosp Epidemiol; 1990 Jan; 11(1):11-2. PubMed ID: 2105351
[No Abstract] [Full Text] [Related]
17. Fusidic acid resistance in Staphylococcus aureus isolates.
Brown EM; Thomas P
Lancet; 2002 Mar; 359(9308):803. PubMed ID: 11888633
[No Abstract] [Full Text] [Related]
18. Bacitracin versus mupirocin for Staphylococcus aureus nasal colonization.
Soto NE; Vaghjimal A; Stahl-Avicolli A; Protic JR; Lutwick LI; Chapnick EK
Infect Control Hosp Epidemiol; 1999 May; 20(5):351-3. PubMed ID: 10349956
[TBL] [Abstract][Full Text] [Related]
19. Increasing rate of detection of fusidic acid resistance in methicillin-resistant Staphylococcus aureus isolated from clinical samples in Malaysia.
Alreshidi MA; Mariana NS
Med J Malaysia; 2011 Aug; 66(3):276. PubMed ID: 22111461
[No Abstract] [Full Text] [Related]
20. Fusidic acid resistance in Staphylococcus aureus.
Dobie D; Gray J
Arch Dis Child; 2004 Jan; 89(1):74-7. PubMed ID: 14709515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
